← feed

Is NCT03006367 results overdue?

Yes — results are overdue. Primary completion was 2017-02-26; the FDAAA-801 reporting deadline (2018-02-26) passed 3037 days ago and no results are posted on ClinicalTrials.gov.

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

NCT IDNCT03006367 ↗
SponsorAevi Genomic Medicine, LLC, a Cerecor company (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-02-26 (ACTUAL)
Reporting deadline2018-02-26 (completion + 365d)
Days overdue3037
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 5cae5e2b7238c431… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03006367. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →